Benzinga | Aug 4, 2020 08:12AM EDT

Evofem Biosciences Q2 GAAP EPS $(0.91) Misses $(0.37) Estimate

Evofem Biosciences (NASDAQ:EVFM) reported quarterly losses of $(0.91) per share which missed the analyst consensus estimate of $(0.37) by 145.95 percent. This is a 4.21 percent increase over losses of $(0.95) per share from the same period last year.